Moreover, ESCCAL-1 cooperates with Gal-1 to promote ESCC proliferation and cell-cycle progression, suggesting that disruption of their interaction may provide novel insight for the diagnosis and treatment of ESCC. This evidence concerns the gene LGALS1 and esophageal squamous cell carcinoma.